236 related articles for article (PubMed ID: 30851551)
1. Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer's disease caused by London familial APP mutation (V717I).
Grigor'eva EV; Malankhanova TB; Ustyantseva EI; Minina JM; Redina OE; Morozov VV; Shevela AI; Zakian SM; Medvedev SP
Stem Cell Res; 2019 Apr; 36():101415. PubMed ID: 30851551
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
[TBL] [Abstract][Full Text] [Related]
3. Generation of a gene-corrected human isogenic iPSC line from an Alzheimer's disease iPSC line carrying the London mutation in APP (V717I).
Hernández D; Morgan Schlicht S; Daniszewski M; Karch CM; ; Goate AM; Pébay A
Stem Cell Res; 2021 May; 53():102373. PubMed ID: 34088002
[TBL] [Abstract][Full Text] [Related]
4. Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene.
Oksanen M; Hyötyläinen I; Voutilainen J; Puttonen KA; Hämäläinen RH; Graff C; Lehtonen Š; Koistinaho J
Stem Cell Res; 2018 Aug; 31():181-185. PubMed ID: 30099334
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.
Rolova T; Wu YC; Koskuvi M; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Koistinaho J; Lehtonen Š
Stem Cell Res; 2020 Oct; 48():101968. PubMed ID: 32911327
[TBL] [Abstract][Full Text] [Related]
6. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
[TBL] [Abstract][Full Text] [Related]
7. Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene.
Frederiksen HR; Holst B; Ramakrishna S; Muddashetty R; Schmid B; Freude K
Stem Cell Res; 2019 Jan; 34():101368. PubMed ID: 30634129
[TBL] [Abstract][Full Text] [Related]
8. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
[TBL] [Abstract][Full Text] [Related]
9. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
[TBL] [Abstract][Full Text] [Related]
10. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cell line (ZZUi0024-A) from a 51-year-old patient with APP gene mutation in Alzheimer' s disease.
Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Wang Y; Xu Y
Stem Cell Res; 2021 May; 53():102267. PubMed ID: 33652304
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cell lines IRMBi003-A and IRMBi003-B from a healthy donor to model Alzheimer's disease.
Clua Provost C; Auboyer L; Rovelet-Lecrux A; Monzo C; Schob E; Andreux F; Quittet C; Lehmann S; Wallon D; Crozet C
Stem Cell Res; 2023 Dec; 73():103250. PubMed ID: 37979430
[TBL] [Abstract][Full Text] [Related]
13. Generation of six human iPSC lines from patients with a familial Alzheimer's disease (n = 3) and sex- and age-matched healthy controls (n = 3).
Raska J; Hribkova H; Klimova H; Fedorova V; Barak M; Barta T; Pospisilova V; Vochyanova S; Vanova T; Bohaciakova D
Stem Cell Res; 2021 May; 53():102379. PubMed ID: 34088008
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation.
Sun W; Wang P; Gong J; Chen Y; Yang Y; Luan H; Li S; Li R; Wei C
Stem Cell Res; 2023 Sep; 71():103149. PubMed ID: 37356183
[TBL] [Abstract][Full Text] [Related]
15. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
16. Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation.
Wang Y; Zhang J; Hu J; Li G; Lei Y; Zhao J
Stem Cell Res; 2019 Apr; 36():101391. PubMed ID: 30831521
[TBL] [Abstract][Full Text] [Related]
17. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
[TBL] [Abstract][Full Text] [Related]
18. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of human induced pluripotent stem cell lines from a familial Alzheimer's disease PSEN1 A246E patient and a non-demented family member bearing wild-type PSEN1.
Muñoz SS; Balez R; Castro Cabral-da-Silva ME; Berg T; Engel M; Bax M; Do-Ha D; Stevens CH; Greenough M; Bush A; Ooi L
Stem Cell Res; 2018 Aug; 31():227-230. PubMed ID: 30138848
[TBL] [Abstract][Full Text] [Related]
20. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
